10X GENOMICS INC-CLASS A (TXG) Stock Balance Sheet
NASDAQ:TXG - Nasdaq - US88025U1097 - Common Stock - Currency: USD
| MRQ (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 377.06M | 344.07M | 359.28M | 219.70M | 587.40M | |||
| Marketable Securities | 49.84M | 49.34M | 29.41M | 210.20M | N/A | |||
| Receivables | 52.55M | 87.86M | 114.83M | 104.20M | 85.30M | |||
| Inventories | 74.71M | 83.11M | 73.71M | 81.60M | 60.00M | |||
| Other Current Assets | 25.57M | 20.02M | 18.79M | 19.20M | 14.90M | |||
| Total Current Assets | 579.73M | 584.39M | 596.02M | 635.00M | 747.60M | |||
| Non-Current Assets | ||||||||
| PPE Net | 301.66M | 309.94M | 344.93M | 359.20M | 230.40M | |||
| Goodwill | 4.51M | 4.51M | 4.51M | 4.50M | 4.50M | |||
| Intangibles | 15.19M | 15.67M | 16.62M | 22.90M | 25.40M | |||
| Other Non-Current Assets | 2.30M | 4.13M | 3.06M | 7.40M | 10.90M | |||
| Total Non-Current Assets | 323.66M | 334.25M | 369.12M | 394.00M | 271.20M | |||
| TOTAL ASSETS | 903.39M | 918.64M | 965.14M | 1.03B | 1.02B | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | N/A | N/A | |||
| Accrued Expenses | 50.35M | 62.00M | 80.70M | 87.70M | 75.80M | |||
| Accounts Payable | 10.07M | 12.91M | 15.74M | 21.60M | 17.40M | |||
| Other Current Liabilities | 47.48M | 42.72M | 30.73M | 21.70M | 17.20M | |||
| Total Current Liabilities | 107.90M | 117.63M | 127.16M | 131.00M | 110.40M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 88.60M | 90.87M | 96.94M | 92.30M | 90.90M | |||
| Total Non-Current Liabilities | 88.60M | 90.87M | 96.94M | 92.20M | 90.90M | |||
| TOTAL LIABILITIES | 196.50M | 208.50M | 224.10M | 223.20M | 201.30M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -1.50B | -1.47B | -1.28B | -1.03B | -863.30M | |||
| Additional Paid In Capital | 2.21B | 2.18B | 2.03B | 1.84B | 1.68B | |||
| Common Shares | 2.00K | 2.00K | 2.00K | 0.00 | 0.00 | |||
| Other Shareholders' Equity | -367.00K | -493.00K | -429.00K | -4.30M | 0.00 | |||
| Shares Outstanding | 123.13M | 122.29M | 119.10M | 115.20M | 112.50M | |||
| Tangible Book Value per Share | 5.58 | 5.64 | 6.04 | 6.76 | 7.00 | |||
| Total Shareholders' Equity | 706.89M | 710.13M | 741.04M | 805.70M | 817.60M | |||
| TOTAL LIABILITIES AND EQUITY | 903.39M | 918.64M | 965.14M | 1.03B | 1.02B | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | N/A | N/A | |||
| Current Ratio | 5.37 | 4.97 | 4.69 | 4.85 | 6.77 | |||
| Return On Assets (ROA) | -17.38% | -19.88% | -26.43% | -16.13% | -5.71% | |||
| Return On Equity (ROE) | -22.21% | -25.72% | -34.42% | -20.60% | -7.12% | |||
All data in USD , ROIC based on taxRate of 0.21